More recently, the biological roles and therapeutic promise of DRDs were revisited when a well-established antagonist of DRD2, thioridazine (TDZ),12 was identified in anti-cancer compound screens for both neural13, 14, 15 and non-neural cancer cells.14 The gene discussed is DRD2; the disease is cancer.